Brief: Wuxi AppTec Owns 38.2 Mln H-shares In JW Cayman Therapeutics
Nov 3 (Reuters) - Wuxi AppTec Co Ltd 603259.SS :
* SAYS AFTER THE LISTING OF JW CAYMAN THERAPEUTICS
2126.HK , THE
COMPANY OWNS 38.2 MILLION H-SHARES IN JW
Source text in Chinese: https://bit.ly/3enWUBN
Further company coverage: 603259.SS 2126.HK 2359.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on JW (Cayman) Therapeutics Co
See all newsChina pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
Brief: JW (Cayman) Therapeutics Appoints Tian Feng As CEO, Executive Director
Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment
Brief: JW (Cayman) Therapeutics H1 Net Income RMB -267.3 Million
Brief: JW (Cayman) Therapeutics Grants Juno Therapeutics Non-Exclusive License